Article
Polymorphisms in the genes ERCC2, XRCC3 and CD3EAP influence treatment outcome in multiple myeloma patients undergoing autologous bone marrow transplantation.
International journal of cancer - 1 Mar 2007
Vangsted Annette, Gimsing Peter, Klausen Tobias W, Nexø Bjørn A, Wallin Håkan, Andersen Pernille, Hokland Peter, Lillevang Søren T, Vogel Ulla
Abstract excerpt
Individual variations in the ability to cope with DNA damage by DNA repair may be essential for the response to chemotherapy, since cancer cells from patients with an effective DNA repair may survive treatment. We have studied the effect on time to treatment failure (TTF) and overall survival (OS) of polymorphism in the DNA repair genes ERCC1, ERCC2 and XRCC3, and in the apoptotic genes PPP1R13L and CD3EAP in 348...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
